Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Variability of cost-effectiveness estimates for pharmaceuticals in Western Europe: lessons for inferring generalizability.
Value Health. 2005 Jan-Feb;8(1):10-23. doi: 10.1111/j.1524-4733.2005.03070.x.
Value Health. 2005.
PMID: 15841890
Free article.
Review.
Early modelling for assessing health and economic outcomes of drug therapy.
Annemans L, Genesté B, Jolain B.
Annemans L, et al. Among authors: jolain b.
Value Health. 2000 Nov-Dec;3(6):427-34. doi: 10.1046/j.1524-4733.2000.36007.x.
Value Health. 2000.
PMID: 16464202
Free article.
Item in Clipboard
Medical care consumption in a phase III trial comparing irinotecan with infusional 5-fluorouracil (5-FU) in patients with metastatic colorectal cancer after 5-FU failure.
Schmitt C, Blijham G, Jolain B, Rougier P, Van Cutsem E.
Schmitt C, et al. Among authors: jolain b.
Anticancer Drugs. 1999 Jul;10(6):617-23. doi: 10.1097/00001813-199907000-00014.
Anticancer Drugs. 1999.
PMID: 10885910
Clinical Trial.
Item in Clipboard
A prospective comparison of four study designs used in assessing safety and effectiveness of drug therapy in hypertension management.
Levine MA, Hamet P, Novosel S, Jolain B.
Levine MA, et al. Among authors: jolain b.
Am J Hypertens. 1997 Nov;10(11):1191-200. doi: 10.1016/s0895-7061(97)00227-6.
Am J Hypertens. 1997.
PMID: 9397236
Clinical Trial.
Item in Clipboard
Is paclitaxel and cisplatin a cost-effective first-line therapy for advance ovarian carcinoma?
Covens A, Boucher S, Roche K, Macdonald M, Pettitt D, Jolain B, Souetre E, Rivière M.
Covens A, et al. Among authors: jolain b.
Cancer. 1996 May 15;77(10):2086-91. doi: 10.1002/(SICI)1097-0142(19960515)77:10<2086::AID-CNCR18>3.0.CO;2-R.
Cancer. 1996.
PMID: 8640674
Item in Clipboard
Cost-effectiveness analysis of lipid-modifying therapy in Canada: comparison of HMG-CoA reductase inhibitors in the primary prevention of coronary heart disease.
Jolain B, Pettitt D.
Jolain B, et al.
Clin Ther. 1995 May-Jun;17(3):572-80. doi: 10.1016/0149-2918(95)80123-5.
Clin Ther. 1995.
PMID: 7585861
No abstract available.
Item in Clipboard
Cite
Cite